Data integrity considerations in Pharma and Life Sciences
European Pharmaceutical Review
MARCH 12, 2024
If data used to support the safety , efficacy and quality of pharmaceutical products is compromised or unreliable, it can lead to regulatory non-compliance, product recalls, and most importantly, harm to patients who depend on those medications. Training and education. How can this be mitigated? Implement quality management systems.
Let's personalize your content